We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
After years of protesting against Pfizer and GlaxoSmithKline’s pneumococcal vaccine pricing, Médecins Sans Frontières is empowering pharma investors to get involved.
Even after Pfizer and GlaxoSmithKline offered up pneumonia vaccine pricing concessions last fall, Médecins Sans Frontières isn’t letting up in its public pressure campaign against the drugmakers.